Sheldon L. Koenig - 17 Jun 2025 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Signature
/s/ Sheldon L. Koenig
Issuer symbol
ESPR
Transactions as of
17 Jun 2025
Net transactions value
-$33,796
Form type
4
Filing time
18 Jun 2025, 18:44:47 UTC
Previous filing
19 Mar 2025
Next filing
18 Sep 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Koenig Sheldon L. President and CEO, Director C/O ESPERION THERAPEUTICS, INC., 3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR /s/ Sheldon L. Koenig 18 Jun 2025 0001766524

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Sale $33,796 -30,474 -1.9% $1.11 1,541,488 17 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to satisfy tax obligation on vested shares of restricted stock units.